BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 23584013)

  • 21. Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistence.
    Baser O; Chalk M; Rawson R; Gastfriend DR
    Am J Manag Care; 2011 Jun; 17 Suppl 8():S222-34. PubMed ID: 21761948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment.
    Rubio G; Jiménez-Arriero MA; Ponce G; Palomo T
    Alcohol Alcohol; 2001; 36(5):419-25. PubMed ID: 11524308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Medical treatment of alcohol dependence].
    Gache P; Siegrist G
    Rev Med Suisse Romande; 1998 Sep; 118(9):767-9. PubMed ID: 9810190
    [No Abstract]   [Full Text] [Related]  

  • 24. [Acamprosate and naltrexone: similar efficacy for relapse].
    Saitz R
    Rev Med Suisse; 2014 Dec; 10(455):2437. PubMed ID: 25752019
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacotherapy for alcohol dependence: anticraving medications for relapse prevention.
    Jung YC; Namkoong K
    Yonsei Med J; 2006 Apr; 47(2):167-78. PubMed ID: 16642544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current pharmacotherapies of alcoholism: a U.S. perspective.
    Anton RF; Swift RM
    Am J Addict; 2003; 12(s1):s53-s68. PubMed ID: 14972780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence: a relative benefits analysis of randomized controlled trials.
    Snyder JL; Bowers TG
    Am J Drug Alcohol Abuse; 2008; 34(4):449-61. PubMed ID: 18584575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of healthcare utilization among patients treated with alcoholism medications.
    Mark TL; Montejano LB; Kranzler HR; Chalk M; Gastfriend DR
    Am J Manag Care; 2010; 16(12):879-88. PubMed ID: 21348558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of acamprosate and opioid antagonists in the treatment of alcohol dependence: a European perspective.
    Soyka M; Chick J
    Am J Addict; 2003; 12(s1):s69-s80. PubMed ID: 14972781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neurobiological mechanisms and pharmacological treatment options for alcohol craving].
    Hillemacher T; Kornhuber J; Bleich S
    Fortschr Neurol Psychiatr; 2007 Jan; 75(1):26-32. PubMed ID: 17031777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Which treatment for alcohol dependence: naltrexone, acamprosate and/or behavioural intervention?
    Doggrell SA
    Expert Opin Pharmacother; 2006 Oct; 7(15):2169-73. PubMed ID: 17020440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical treatment of alcohol dependence: a systematic review.
    Miller PM; Book SW; Stewart SH
    Int J Psychiatry Med; 2011; 42(3):227-66. PubMed ID: 22439295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent advances in the pharmacotherapy of alcoholism.
    Myrick H; Anton R
    Curr Psychiatry Rep; 2004 Oct; 6(5):332-8. PubMed ID: 15355755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of the combination of naltrexone and acamprosate on alcohol intake in mice.
    Kim SG; Han BD; Park JM; Kim MJ; Stromberg MF
    Psychiatry Clin Neurosci; 2004 Feb; 58(1):30-6. PubMed ID: 14678454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationale for combining acamprosate and naltrexone for treating alcohol dependence.
    Mason BJ
    J Stud Alcohol Suppl; 2005 Jul; (15):148-56; discussion 140. PubMed ID: 16223066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent developments in the pharmacotherapy of alcohol dependence.
    Schuckit MA
    J Consult Clin Psychol; 1996 Aug; 64(4):669-76. PubMed ID: 8803356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Depression in alcohol addicted patients].
    Ponizovskiy PA; Gofman AG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(7):146-150. PubMed ID: 26356528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological mechanisms of naltrexone and acamprosate in the prevention of relapse in alcohol dependence.
    Littleton J; Zieglgänsberger W
    Am J Addict; 2003; 12(s1):s3-s11. PubMed ID: 14972776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acamprosate and naltrexone treatment for alcohol dependence: an evidence-based risk-benefits assessment.
    Mason BJ
    Eur Neuropsychopharmacol; 2003 Dec; 13(6):469-75. PubMed ID: 14636963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical and clinical pharmacology of alcohol dependence.
    Tambour S; Quertemont E
    Fundam Clin Pharmacol; 2007 Feb; 21(1):9-28. PubMed ID: 17227441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.